These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32812325)

  • 1. Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8
    Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Lens S; Leonel T; Bartres C; García-López M; Rodriguez-Tajes S; Forns X; Koutsoudakis G
    J Viral Hepat; 2020 Dec; 27(12):1408-1418. PubMed ID: 32812325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
    Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
    J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy.
    Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Bartres C; González P; García-López M; Pose E; Lens S; Maini MK; Forns X; Koutsoudakis G
    Front Immunol; 2020; 11():129. PubMed ID: 32161581
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
    Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
    Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.
    Llorens-Revull M; Costafreda MI; Rico A; Guerrero-Murillo M; Soria ME; Píriz-Ruzo S; Vargas-Accarino E; Gabriel-Medina P; Rodríguez-Frías F; Riveiro-Barciela M; Perales C; Quer J; Sauleda S; Esteban JI; Bes M
    PLoS One; 2021; 16(7):e0254243. PubMed ID: 34242330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of HCV-specific CD8+ T cell function by interferon-free therapy.
    Martin B; Hennecke N; Lohmann V; Kayser A; Neumann-Haefelin C; Kukolj G; Böcher WO; Thimme R
    J Hepatol; 2014 Sep; 61(3):538-43. PubMed ID: 24905492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis.
    Cacciola I; Russo G; Filomia R; Pitrone C; Caccamo G; Giandalia A; Alibrandi A; Stella Franzè M; Porcari S; Maimone S; Saitta C; Squadrito G; Raimondo G
    Liver Int; 2021 Sep; 41(9):2059-2067. PubMed ID: 33894103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8
    Vranjkovic A; Deonarine F; Kaka S; Angel JB; Cooper CL; Crawley AM
    Front Immunol; 2019; 10():1926. PubMed ID: 31456810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral PD-1
    Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
    Front Immunol; 2019; 10():1470. PubMed ID: 31316516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
    Callendret B; Eccleston HB; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
    Hepatology; 2016 May; 63(5):1442-54. PubMed ID: 26513111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
    Casey JL; Feld JJ; MacParland SA
    Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lasting differential gene expression of circulating CD8 T cells in chronic HCV infection with cirrhosis identifies a role for Hedgehog signaling in cellular hyperfunction.
    Li J; Vranjkovic A; Read D; Delaney SP; Stanford WL; Cooper CL; Crawley AM
    Front Immunol; 2024; 15():1375485. PubMed ID: 38887299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased peripheral CD4
    Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
    J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8
    Winkler F; Hipp AV; Ramirez C; Martin B; Villa M; Neuwirt E; Gorka O; Aerssens J; Johansson SE; Rana N; Llewellyn-Lacey S; Price DA; Panning M; Groß O; Pearce EL; Hermann CM; Schumann K; Hannibal L; Neumann-Haefelin C; Boettler T; Knolle P; Hofmann M; Wohlleber D; Thimme R; Bengsch B
    Gut; 2023 Oct; 72(10):1971-1984. PubMed ID: 37541771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
    Hartlage AS; Walker CM; Kapoor A
    J Virol; 2020 May; 94(10):. PubMed ID: 32102885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis.
    Maan R; van Tilborg M; Deterding K; Ramji A; van der Meer AJ; Wong F; Fung S; Sherman M; Manns MP; Cornberg M; Hansen BE; Wedemeyer H; Janssen HL; de Knegt RJ; Feld JJ
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1821-1830.e6. PubMed ID: 27404965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis.
    Bailly F; Pradat P; Virlogeux V; Zoulim F
    Dig Dis; 2015; 33(4):613-23. PubMed ID: 26159282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8
    Osuch S; Laskus T; Perlejewski K; Berak H; Bukowska-Ośko I; Pollak A; Zielenkiewicz M; Radkowski M; Caraballo Cortés K
    Front Immunol; 2022; 13():832206. PubMed ID: 35386708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.